The most common protocols involve: Semaglutide microdose protocol: Starting at 0.05 mg weekly, holding for 4 weeks, then reassessing inflammatory markers before considering any adjustment
Day JW, Ottaway N, Patterson JT et al (2009) A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
10.1007/BF01067421 172 LiT
Hunger poses one of the toughest obstacles in the weight loss journey
adult population, took the plunge into semaglutides (the generic term for anti-diabetic/anti-obesity drugs Ozempic, Wegovy, Mounjaro, etc.) this past year
Just like high blood pressure or diabetes, it often requires ongoing management